Inventiva IVA
NASDAQ IVA
$3.46 -0.23 (-6.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Inventiva (IVA) EBIT Margin (2020 - 2021)

Updated

Inventiva (IVA) posted EBIT Margin of -3145.51% for FY2025, down 2084.86 percentage points from -1060.64% in FY2024.

Analysis

Inventiva (IVA) EBIT Margin (2020 - 2021) Analysis & Trends

Since FY2018, Inventiva has reported EBIT Margin for 8 years.

  • Annual EBIT Margin has declined for three consecutive years, though with a five-year change of +4843.20 percentage points (FY2020 to FY2025).
  • The FY2025 figure stands as the lowest annual EBIT Margin since FY2020.
  • Business Quant data shows IVA's EBIT Margin at -1060.64% in FY2024 (-472.96 pp), -587.68% in FY2023 (-118.76 pp), -468.92% in FY2022 (+773.66 pp) and -1242.58% in FY2021 (+6746.13 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 Inventiva 713.04 Mn 713.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -21,021.54%
Mar 31, 2021 -13,435.14%
Jun 30, 2020 -11,972.97%
Mar 31, 2020 -7,821.84%
API Access

Inventiva EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IVA&period=max&api_key=YOUR_API_KEY